Tango Therapeutics
TNGX · NASDAQ
$25.25+$1.72 (+7.31%)TodayMarket closed ·
Prev close $23.53
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 100.2% on average
Next report: , before the market opens
- Quarter
- Q3 FY26
- EPS estimate
- -$0.35
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.3248 | -$0.37 | −13.9% |
| Q1 FY26 | -$0.3196 | -$0.32 | −0.1% |
| Q4 FY25 | -$0.3264 | -$0.29 | +11.2% |
| Q3 FY25 | -$0.0538 | $0.14 | +360.2% |
| Q2 FY25 | -$0.3548 | -$0.35 | +1.4% |
| Q1 FY25 | -$0.357 | -$0.36 | −0.8% |
| Q4 FY24 | -$0.3456 | -$0.35 | −1.3% |
| Q3 FY24 | -$0.3745 | -$0.27 | +27.9% |
Earnings calls
- Special Call - Tango Therapeutics, Inc.
- 44th Annual J.P. Morgan Healthcare Conference
- Special Call - Tango Therapeutics, Inc.
- Goldman Sachs 46th Annual Global Healthcare Conference 2025
- 2024 Cantor Fitzgerald Global Healthcare Conference
- Goldman Sachs 45th Annual Global Healthcare Conference
- Barclays 26th Annual Global Healthcare Conference 2024
- Jefferies 2023 Global Healthcare Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.